Patent holdings for IPC class A61P 19/06

Total number of patents in this class: 870

10-year publication summary

28
33
47
77
70
70
88
68
75
38
2017 2018 2019 2020 2021 2022 2023 2024 2025 2026

Principal owners for this class

Owner
All patents
This class
Teijin Pharma Limited
258
19
Nippon Chemiphar Co., Ltd.
225
16
Jiangsu Atom Bioscience and Pharmaceutical Co., Ltd.
31
16
Kissei Pharmaceutical Co., Ltd.
177
15
Takeda Pharmaceutical Company Limited
2713
11
Daiichi Sankyo Company, Limited
1892
10
China Pharmaceutical University
355
9
Horizon Therapeutics USA, Inc.
56
9
LG Chem, Ltd.
17903
8
Pfizer Inc.
3373
8
Banyu Pharmaceutical Co., Ltd.
45
8
Hinova Pharmaceuticals Inc.
99
8
Hangzhou Grand Biologic Pharmaceutical Inc.
17
8
Xiangbei Welman Pharmaceutical Co., Ltd.
35
7
Bristol-myers Squibb Company
4774
6
Ardea Biosciences, Inc.
68
6
Jiangsu Hengrui Medicine Co., Ltd.
693
6
Nippon Shinyaku Co., Ltd.
321
6
Proabtech Co., Ltd.
11
6
Dongbao Purple Star (Hangzhou) Biopharmaceutical Co., Ltd.
10
6
Other owners 682